The conventional methods developed to prevent and eradicate the
prevalence of cancer have achieved limited success in cancer treatment.
These methods are confined to low specificity, safety and large number
of side effects, which prompted the researchers to look for a better
solution. It has been discovered that peptides can be used for effective
and viable treatment of cancer without having disadvantages of
conventional methods. The quintessential for using peptide cancer
therapeutics is that they have high specificity, safety and efficacy
which is not provided by therapeutics available in market.

The completion of human genome sequencing has helped in the research and
development of peptide cancer therapeutics. The data allowed the
researchers to look deep into the root cause of cancer hidden in human
genome. This has allowed targeting cancer cells with high accuracy;
thus, increasing the probability of treatment with high success rates.
Using this data several novel molecules are being developed, which will
have higher stability, effective delivery and minimal or no side-effects.

Peptide cancer therapeutics has edge in treating rare type of cancers.
Conventional approaches of cancer treatments are unable to treat them
successfully. Sometimes these approaches cannot be used due to
unspecificity or they are not effective at all. For instance, brain
cancer is a rare type of cancer that falls in this category.